TipRanks
Newron Pharmaceuticals SpA (DE:NP5)
XETRA:NP5

Compare Newron Pharmaceuticals SpA (NP5) vs. Competitors

3 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Compare
Top Analysts' Price Target
Smart Score
Follow
Newron Pharmaceuticals SpA
€13.45
€173.41M
-5.59
-48.41%
2 Buy
0 Hold
0 Sell
Moderate Buy
Addex Therapeutics
―
CHF2.74M
-0.49
-64.62%
―
Molecular Partners AG
CHF3.41
CHF129.60M
-2.36
7.00%
―
Idorsia Ltd
CHF5.34
CHF1.13B
-3.20
-8.74%
1 Buy
1 Hold
0 Sell
Moderate Buy
Santhera Pharmaceuticals Holding
CHF15.56
CHF218.76M
-6.26
38.37%
―
MindMaze Therapeutics Holding SA
CHF0.19
CHF25.70M
-2.13
-95.70%
―

Performance Comparison

Ticker
Company Name
Price
Change
% Change
DE:NP5
Newron Pharmaceuticals SpA
8.44
-8.06
-48.85%
CH:ADXN
Addex Therapeutics
0.02
-0.04
-61.67%
CH:MOLN
Molecular Partners AG
3.21
0.20
6.64%
CH:IDIA
Idorsia Ltd
4.20
0.30
7.64%
CH:SANN
Santhera Pharmaceuticals Holding
14.28
4.51
46.16%
CH:MMTX
MindMaze Therapeutics Holding SA
0.14
-2.82
-95.20%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts